Cadrenal Therapeutics Provides First Quarter 2023 Corporate Update

AFIBDelisted Stock  USD 0.73  0.03  3.95%   
About 62% of Acutus Medical's investor base is looking to short. The analysis of overall sentiment of trading Acutus Medical stock suggests that many investors are alarmed at this time. The current market sentiment, together with Acutus Medical's historical and current headlines, can help investors time the market. In addition, many technical investors use Acutus Medical stock news signals to limit their universe of possible portfolio assets.
  
Cadrenal Therapeutics, Inc., a biopharmaceutical company focused on developing tecarfarin, a late-stage novel cardiorenal therapy with orphan drug and Fast Track designations, today provided a corporate update in connection with todays filing of its Quarterly Report on Form 10-Q for the quarter ended March 31, 2023.

Read at finance.yahoo.com
Yahoo News
  

Acutus Medical Fundamental Analysis

We analyze Acutus Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Acutus Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Acutus Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Price To Book

Price To Book Comparative Analysis

Acutus Medical is currently under evaluation in price to book category among its peers. Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.

Acutus Medical Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Acutus Medical stock to make a market-neutral strategy. Peer analysis of Acutus Medical could also be used in its relative valuation, which is a method of valuing Acutus Medical by comparing valuation metrics with similar companies.

Peers

Acutus Medical Related Equities

AIMDAinos   4.44   
0%
82.0%
CVRXCVRx   3.20   
0%
59.0%
ATECAlphatec Holdings   1.21   
0%
22.0%
AORTArtivion   0.95   
0%
17.0%
ANIKAnika Therapeutics   0.62   
0%
11.0%
LNSRLENSAR   0.46   
0%
8.0%
OFIXOrthofix Medical   0.06   
0%
1.0%
SSKNSTRATA Skin   0.35   
6.0%
0%
DCTHDelcath Systems   0.87   
16.0%
0%
NPCENeuropace   2.62   
48.0%
0%
AXDXAccelerate Diagnostics   2.73   
50.0%
0%
AXGNAxogen   5.41   
100.0%
0%
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.

Other Consideration for investing in Acutus Stock

If you are still planning to invest in Acutus Medical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Acutus Medical's history and understand the potential risks before investing.
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.